INTRODUCTION
T HIS EDITORIAL PROVIDES a review of the lectures and abstracts presented at Digestive Disease Week 2016 in San Diego, CA, USA on advances in therapeutic upper gastrointestinal procedures. There were a significant number of reports on expanded indications for endoscopic submucosal dissection (ESD) of early gastric cancers, advanced endoscopic techniques for resection including submucosal tunnel endoscopic resection (STER) and endoscopic fullthickness resection (EFTR), peroral endoscopic myotomy (POEM), and novel endoscopic techniques including antireflux mucosectomy (ARMS) as well as endoscopic suturing.
NEW EVIDENCE ON EXPANDED INDICATIONS FOR ENDOSCOPIC RESECTION OF EARLY GASTRIC CANCER
A CCORDING TO THE Japanese gastric cancer treatment guidelines in 2010, the expanded indications for ESD were regarded as an investigational treatment for early gastric cancer (EGC). 1 A multi-center single-arm trial (JCOG0607) evaluated the efficacy and safety of ESD for expanded criteria EGC in 470 patients with cT1a nonulcerative differentiated adenocarcinoma >2 cm or ulcerative tumors <3 cm. 2 Although complete curative resection (CCR) was achieved in only 317 patients (67%), the 5-year overall survival (OS) among all patients was 97.0% (95% CI: 95.0-98.2%), which was higher than the threshold 5-year OS of 86.1%. This suggests that ESD is a suitable treatment option for expanded criteria EGC. A study has externally validated an 11-point and a seven-point lymph node metastasis (LNM) prediction model based on tumor size, depth, histological type, ulcerative finding, and lymphovascular involvement. 3, 4 With the 11-point and seven-point models, the area under the receiver operating characteristic (AUROC) curve of the models in the validation set were 0.82 (95% CI: 0.75-0.88) and 0.77 (0.69-0.85) respectively. These scoring systems will allow more accurate prediction of LNM and help select EGC patients for ESD.
ADVANCES IN TECHNIQUES FOR CARRYING OUT GASTRIC ESD

F
OUR METHODS OF EFTR were described during DDW: (i) laparoscopic endoscopic cooperative surgery (LECS); (ii) laparoscopic-assisted EFTR (LAEFR); (iii) inverted LECS; and (iv) non-exposure full-thickness wall resection (NEWS). The technique of NEWS involves making a circumferential seromuscular incision laparoscopically, with only the seromuscular layer sutured, followed by cutting the mucosal and submucosal layer with the ESD technique. 5 A development of LECS is CLEAN-NET (combination of laparoscopic and endoscopic approaches to neoplasia with the non-exposure technique) which involves dissection of the seromuscular layer with a laparoscopic electrocautery knife, followed by lifting the full-layer specimen by stay sutures. Resection was carried out with a laparoscopic linear stapler inside the peritoneal cavity. 6 EGC with submucosal invasion is associated with a 9-13% LNM risk. 7, 8 
PERORAL ENDOSCOPIC MYOTOMY: LATEST ADVANCES
G LOBALLY, MORE THAN 5000 cases of POEM have been carried out for treatment for achalasia. In this DDW, Inoue reported a single-center Japanese series of 1000 cases confirming the safety and efficacy of POEM. 7 Overall success was 95.4% as defined by post-procedure Eckardt score of lesser than or equal to 3. Thirty (3%) patients developed recurrence and all were treated by redo-POEM. No major complications were observed whereas 31 (3.1%) patients had minor complications.
A multicenter study reported on the clinical outcomes of patients with follow up longer than 2 years. It demonstrated a 24% rate of gastroesophageal reflux after POEM. 8 The largest US series to date from the USA reported data based on 284 patients. 10 Interestingly, 139 (49%) had previous treatment including 103 who received balloon dilatation, 62 who received Botox injection, 41 had Heller's myotomy and five had previous POEM. Efficacy (Eckardt score ≤3) was 94% at 3 months, 94% at 6 months and 92% at 12 months. At 3 months, 68 of 137 (50%) patients had endoscopic evidence of reflux esophagitis and 63 of 136 (46%) patients had confirmed reflux with Bravo â pH monitoring (Medtronics, Minneapolis, MN, USA). A retrospective study carried out from 2009 to 2015 consisted of 1826 patients from 12 international academic centers to assess the adverse event rate. 11 A total of 156 (8.5%) adverse events occurred in 137 of the 1826 patients. Of the total 1826 patients, only nine (0.5%) adverse events were classified as severe. No mortality was observed. Of note, the operative time for POEM cases with subsequent adverse events was longer than for uneventful cases (123 AE 49 min versus 103 AE 48 min [P = 0.002]). Another multicenter international retrospective study analyzed 46 patients with redo-POEM. 12 The clinical success rate was 85%. The adverse event rate was 17%, all of which were bleeding-related complications, and were successfully managed endoscopically.
Further evidence has also been gathered to demonstrate the comparability of POEM and laparoscopic Heller's myotomy (LHM) in terms of safety and efficacy. 13 A recent meta-analysis of 196 POEM and 290 LHM subjects from non-randomized comparative studies showed that there was no difference in terms of postoperative improvement in Eckardt score, operative time, postoperative pain or adverse event rate.
14 In contrast to previous studies, length of hospital stay was significantly lower for POEM (MD = À0.629, 95% CI: À1.256 to À0.002, P = 0.049). There was a trend that favors LHM for lower postoperative symptomatic reflux rate (OR = 1.81, 95% CI: 1.11-2.95, P = 0.017). The results of a German multicenter randomized controlled trial comparing POEM versus LHM are eagerly awaited. 15 An international retrospective casecontrolled study compared the outcomes of 90 POEM patients with prior history of LHM against 90 control patients. 16 Majority of patients (97%) with previous Heller's myotomy (HM) received posterior POEM. Other operative characteristics including operative time and myotomy length were similar. With a median follow up of 8.5 months, clinical success was 94% in the control group compared to 80% in the previous HM group (P = 0.02).
Currently, one of the important controversies on refining the technique of POEM is whether myotomy should be carried out by the anterior or by the posterior approach. A retrospective study that consisted of 284 cases compared 131 patients who received anterior POEM to 153 with posterior POEM. 17 Mucosal injury rate was similar between the techniques. Posterior POEM was associated with higher narcotic analgesia use 
ADVANCED UPPER GI ENDOSCOPIC PROCEDURES
D EVELOPMENT OF ENDOSCOPIC resection of EGC has progressed from endoscopic mucosal resection (EMR) to ESD and now to EFTR and natural orifice translumenal endoscopic surgery (NOTES).
18 Various methods for closure of the mural defect after EFTR have been developed including string suture with endoloop and metallic clips and over-the-scope clips (OTSC). A nonrandomized multicenter study compared 28 patients with novel LeCamp TM endoloop (LeCamp, Changzhou, China) and 36 patients with OTSC for EFTR. 19 Both groups demonstrated no differences in closure time and readmission rate. Average times for removing the nasogastric tube and hospital stay were longer in the endoloop group, but no complication was reported. The authors concluded that the novel endoloop technique was feasible and safe. The innovative approach in submucosal tunneling has led to the development of submucosal tunneling endoscopic resection (STER) or peroral endoscopic tumor resection (POET) for the treatment of gastrointestinal subepithelial tumors. 20, 21 Chiu et al. described a prospective series of 30 patients with gastric subepithelial tumors located at the cardia, lesser curvature and antrum. 22 Mean size of submucosal tumor (SMT) was 23.8 AE 16.1 mm, and mean operative time was 103.3 AE 50.5 min. Operative stay was 3.2 days, and one SMT was considered too large for POET and was treated by EFTR. No tumor recurrence was observed during follow up (mean follow up: 19 months). Another prospective study reported 62 resections, including 14 STER and 48 EFTR for treatment of gastrointestinal subepithelial tumors (SET), in which the en-bloc resection rate was 92%. 23 One point worth noting is the occurrence of significant complications, including three cases of bleeding requiring prolonged hemostasis during the procedure, as well as conversion to laparoscopic resection because of large paratumoral vessels. With the current technologies in endoscopic resection, careful selection of appropriate SET as well as expertise in carrying out STER and EFTR are essential to ensure a safe and effective procedure. For example, it has been reported that the success rate of POET (STER) is 100% if tumor size is <4 cm, whereas the success rate decreases to 30% for tumors >5 cm. 22, 23 Over the past decade, numerous endoscopic antireflux procedures have been investigated for the treatment of GERD. 24 Development of these procedures aimed to improve lower esophageal sphincter (LES) pressure through creation of an antireflux valve over the gastroesophageal junction (GEJ), or to reduce esophageal sensitivity to acid reflux. Endoscopic antireflux procedures can be classified into: (i) radiofrequency ablation at the GEJ; (ii) injection/implantation techniques; and (iii) plication/suturing of the LES/GEJ. Currently, available technologies for endoscopic antireflux procedures include Stretta (Mederi Therapeutics Inc., Norwalk, CT, USA) for radiofrequency ablation and EsophyX â for suture (EndoGastric Solutions, Redmond, WA, USA) application at the GEJ to restore the valve. Two prospective randomized trials were conducted to investigate the effect of transoral incisionless fundoplication (TIF) using EsophyX against proton pump inhibitor (PPI) for the treatment of GERD. 24, 25 The RESPECT trial, which recruited 129 patients, demonstrated significant improvement in troublesome regurgitation in 67% of patients who received TIF compared to 45% of PPI/sham patients (P = 0.023). 24 Moreover, TIF resulted in significant improvement in pH profile with a higher response rate compared to sham therapy (89% vs 64%; P = 0.004). The TEMPO multicenter trial compared TIF to PPI in 63 patients with GERD, and results showed that troublesome regurgitation was eliminated in 97% of TIF patients against 50% of PPI patients (P = 0.006). 25 Inoue et al. first reported the success of antireflux mucosectomy (ARMS) for treatment of GERD in 10 patients with a significant reduction in symptom score and significant improvement in % total time pH <4 from 29.1% to 3.1%. 26 Mucosectomy should be targeted at the gastric cardia along the lesser curvature while achieving a semi-circumferential resection. Generally, ARMS was carried out by the techniques of cap EMR in a retroflex position. Of the 26 patients who received ARMS, 65% were off PPI at 1 year after the procedure. Thirty percent of patients had dysphagia after ARMS, 26.7% of cases required one-time pneumatic dilatation, whereas 6.7% patients required more than two instances of endoscopic dilatation. ARMS is potentially suitable for patients who have refractory GERD and do not have large hiatal hernia. Long-term study is necessary to confirm its efficacy.
CONCLUSIONS W E HAVE SEEN great advancements in therapeutic endoscopy. Increasing evidence suggests that ESD for expanded criteria EGC can achieve both oncological clearance and clinical safety. Novel scoring systems may help predict gastric cancer lymph node metastasis and may help clinicians select the most appropriate therapy: endoscopic resection alone or combined endo-laparoscopic resection with lymph node dissection. Significant volume of new evidence confirms clinical safety and efficacy of POEM. It may be time for POEM to be considered the goldstandard treatment for achalasia. Moreover, bold advances including endoscopic full-thickness resection, novel endoscopic mural closure methods, endoscopic submucosal tumor resection and endoscopic antireflux procedures will surely continue to expand the realm of therapeutic endoscopy. With more evidence, we may see these novel techniques become applicable in daily practice.
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